SAN DIEGO, Calif. (August 11, 2014)—ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.
ResMed’s new Air Solutions platform is where connected care begins. The Air Solutions platform includes the AirSense 10 Series of flow generators and the AirFit family of masks, along with new software solutions for capturing, monitoring and maximizing patient compliance.
"With Air Solutions, we're creating a new beginning in patient care," said Don Darkin, president of the ResMed Sleep-Disordered Breathing Business Unit. "As we unveil each Air Solutions component, our signature differentiation of superior performance and comfort will be underscored, made even stronger with groundbreaking technology that helps providers become more connected with their patients."
Air Solutions comprises components that, together, create a comprehensive end-to-end ecosystem that directly addresses the pain points for each stakeholder in the patient's therapy, including physicians, sleep labs, home medical equipment providers and the patients themselves. The ecosystem approach, Darkin says, can increase efficiency and treatment efficacy by keeping providers informed and patients engaged. Included in the Air Solutions platform are:
ApneaLink Air: ResMed's compact and lightweight home sleep testing device works seamlessly with AirView software (see below) to empower sleep labs to efficiently manage each step of the diagnostic process, and share data to appropriate user groups.
AirSense 10 Series: ResMed's new series of continuous and automatic positive airway pressure devices (CPAP and APAP), called AirSense 10, that have advanced data and communications features to streamline the set-up, compliance management and compliance monitoring processes. This brand-new device platform is also intuitive and easy-to-use and offers a smaller bedside footprint.
AirCurve 10 Series: The AirCurve 10 series includes a range of bi-level devices that meet a variety of patient conditions and needs, such as patients who need extra pressure support, as well as an ASV device for patients with Cheyne-Stokes respiration or who require adaptive-servo-ventilation.
AirFit Masks: Announced earlier this year, the AirFit masks are known by their easy fit and superior comfort. The AirFit line includes the AirFit P10 nasal pillows system, which is the current market leader among new patients, the AirFit F10 full-face mask and the AirFit N10 nasal mask.
AirView Monitoring and Compliance Management System: When used in conjunction with Air Solutions devices, the AirView software solution significantly streamlines the patient management process by providing troubleshooting, fault detection and more. AirView enables data on demand, with patient data available just one hour after a patient's therapy session has ended.
myAir Patient Engagement Application and Software: An engaged patient is more likely to be compliant, and myAir helps patients better understand their sleep data, with data dashboards, coaching and reinforcement messages.
ApneaLink Air and AirFit masks are available now in the U.S. and other select markets. The AirSense 10 and AirView will be available in the U.S. and Australia Aug. 18, and other markets later this year. The AirCurve 10 Series and myAir will also be available later this year.
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing and managing sleep-disordered breathing, COPD and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information, visit resmed.com.
